Month: December 2020

This is a joint press release by Sanofi (“Sanofi“) and Kiadis Pharma N.V. (“Kiadis“), pursuant to the provisions of Section 4, paragraph 3 of the Netherlands Decree in Public Takeover Bids (Besluit openbare biedingen Wft) and Section 17 paragraph 1 of the European Market Abuse Regulation (596/2014), in connection with the intended public offer by Sanofi for all the issued and outstanding ordinary shares in the capital of Kiadis (the “Offer“). This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means of an offer memorandum (the “Offer Document“) approved by the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten) (the “AFM“) and recognized by the Belgian Authority...

Muttenz, December 9, 2020 – Clariant, a focused, sustainable and innovative specialty chemical company, today announced that Conrad Keijzer will become Clariant’s new Chief Executive Officer. The Board of Directors has appointed him in its meeting yesterday evening. Conrad Keijzer will officially join the company as of January 1, 2021. Executive Chairman ad interim Hariolf Kottmann will then return to his position as Chairman of the Board.  Conrad Keijzer (52) is a Dutch citizen with a long and successful track record in the chemical industry, most notably his 24 years with the leading global paints and coatings manufacturer AkzoNobel. At AkzoNobel, he last held the position as CEO of the Performance Coatings Division and was a member of the Executive Committee. Most recently, Conrad Keijzer was CEO at Imerys, the French supplier of mineral-based...

Press ReleaseDecember 9, 2020Signify presents strategy to drive profitable growth and provides update on 2020 outlook and new financial guidance for 2021-2023 at Capital Markets DayEindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today holds a virtual Capital Markets Day from 14:00 till 18:00 CET. During the event, Signify will provide further details on its strategic plan and performance trajectory for 2021-2023.“The general lighting market underwent a radical transformation, moving from conventional to LED and to connected lighting. Today, we will outline our intent to further strengthen our leadership, targeting attractive growth and profit pools,” said Eric Rondolat, CEO of Signify. “Looking ahead, we expect the headwinds facing our industry from the transition to LED to abate over the coming years....

Moderna’s vaccine triggers an antibody response to the SARS-CoV-2 spike proteinThe Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine trial participants and could help to establish correlation to protection from COVID-19Emergency Use Authorisation by the US FDA for the Elecsys Ab test was granted on 25 Nov, 2020Basel, 9 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 antibodies and help to establish a correlation between vaccine-induced protection and levels of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers antibody...

REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) — PubMatic, Inc. (Nasdaq: PUBM) today announced the pricing of its initial public offering of 5,900,000 shares of Class A common stock at a price to the public of $20.00 per share. PubMatic is offering 2,655,000 shares and certain selling stockholders are offering 3,245,000 shares. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to 885,000 additional shares of common stock at the initial public offering price, less underwriting discounts. PubMatic will not receive any proceeds from any sale of shares by the selling stockholders.The shares are expected to begin trading on the Nasdaq Global Market on December 9, 2020 under the ticker symbol “PUBM.” The offering is expected to close on December 11, 2020, subject to customary closing...

This decision is a result of the Government’s tightened restrictionst o get the infection with COVID-19 under control.On top of the press conference on Monday 7 December in the Prime Minister’s Office, Tivoli, in consultation with its board, has decided to close down from Wednesday 9 December and for the rest of the Christmas season. Tivoli perceives the Government’s and the authorities’ message as clear and unambiguous: We must see each other and gather as little as possible across the board until the infection rates are under control, especially in municipalities where stricter restrictions have been introduced. Every time new restrictions has been introduced, Tivoli has implemented extra measures so that there should be no doubt that the safety of our guests and staff is above all else.Tivoli’s business is based...

Tivoli har i dag måttet tage den svære beslutning at lukke haven for gæster fra den 9. december, som følge af Regeringens nye skærpede restriktioner for at få smitten med COVID-19 under kontrolOven på pressemødet i Statsministeriet mandag den 7. december har Tivoli besluttet at lukke ned fra og med onsdag den 9. december og i resten af julesæsonen. Tivoli opfatter Regeringens og myndighedernes budskab som klart og entydigt: Vi skal ses og være sammen mindst muligt på kryds og tværs, indtil smittetallene er under kontrol, især i kommuner, hvor der er indført skærpede restriktioner. Hver gang, der er kommet nye restriktioner, har Tivoli indført ekstra foranstaltninger, for at der ikke skulle herske nogen tvivl om, at gæsternes og medarbejdernes tryghed står over alt andet.Tivolis forretning hviler på fire hovedaktiviteter, der komplimenterer...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), is a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector. The Company is pleased to announce that it has signed a letter of intent (LOI) with The Nutraceutical Medicine Company Inc. (“PURICA”), owner of the PURICA™ brand of full-spectrum mushroom derived wellness products, to support Pure Extracts’ expansion into the functional mushroom sector and to co-develop CBD-full-spectrum mushroom wellness combinations.PURICA has a track record of more than 20 years of bringing its customers the very best that nature has to offer; skillfully-formulated natural and whole food products solidly-backed by science. Based in Duncan,...

VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) is pleased to announce the appointment of Sarj Dhaliwal as Chief Financial Officer of the Company. Sarj Dhaliwal is a CPA (CA) with extensive experience in high growth technology companies. Ms. Dhaliwal brings a unique blend of senior finance, operations, sales, and marketing experience to the Company.The Company further announces the appointment of Ron Fraser as Chief Operating Officer of the Company. Mr. Fraser’s mechanical design engineering background encompasses the mining, oil, and gas sectors on mega projects around the world based in Vancouver.About AffinorAffinor is a publicly traded company on the CSE under the symbol “AFI” and on the OTCQB under the symbol “RSSFF”. Affinor...

TAMPA, Fla., Dec. 08, 2020 (GLOBE NEWSWIRE) — BRP Group, Inc. (“BRP” or the “Company”) (NASDAQ: BRP) today announced the pricing of its offering of 8,750,000 shares of its Class A common stock at a price to the public of $29.50 per share. The underwriters for the offering also have a 30-day option to purchase up to 1,312,500 additional shares of its Class A common stock. BRP Class A common stock trades on the Nasdaq Global Select Market under the ticker symbol “BRP.” The offering is expected to close on December 11, 2020, subject to customary closing conditions.BRP intends to use a portion of the net proceeds from the sale of the shares of Class A common stock offered in the offering to purchase newly issued membership interests of Baldwin Risk Partners, LLC (“LLC Units”) from its operating subsidiary Baldwin Risk Partners, LLC....